Puration Wraps Arnold Sports Festival With New Orders, Opportunities and Partnerships
March 04 2019 - 1:43PM
InvestorsHub NewsWire
Puration Wraps Arnold Sports
Festival With New Orders, Opportunities and Partnerships
Dallas, TX -- March 4, 2019 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today announced a presentation scheduled, Thursday this
week, March 7th, 2018 to review new orders,
opportunities and partnerships stemming from the EVERx CBD Sports
Water event this past weekend at the Arnold Sports Festival.
“We got our tires kicked at the Arnold by some very large
distributors that would substantially change our trajectory,” said
Brian Shibley, CEO of PURA. EVERx CBD Sports Water debuted
it’s all new formula and packaging at the
world-renowned Arnold Sports
Festival this week in Columbus, Ohio where EVERx
launched for the first time ever in
2017.
Arnolds Sprots Festival Award
Presentation Models
Analyst Speculative Buy Recommendation and
$0.25 PPS Target with $0.35
Upside
Goldman Small Cap Research issued a
research update on Puration, Inc. (USOTC:
PURA) last week recommending
a 'speculative-buy' rating with a target
price-per-share of $0.25, with noted potential upside to the
$0.35 mark.
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From May 2024 to Jun 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Jun 2023 to Jun 2024